The Globe and Mail reports in its Tuesday, March 10, edition that Desjardins Securities analyst Chris MacCulloch has reaffirmed his "buy" recommendation for Tourmaline Oil. The Globe's David Leeder writes in the Eye On Equities column that Mr. MacCulloch gave his share target a $4 boost to $74. Analysts on average target the shares at $68.89. Mr. MacCulloch says in a note: "We were perplexed by [the] negative market response to what we viewed as an overwhelmingly constructive update. Specifically, the company strengthened the sustainability of its business model through margin-enhancing initiatives, a leaner capital program and a more disciplined dividend policy—all critical improvements which will support long-term growth plans." The Globe reported on April 16, May 13 and Nov. 11 that Mr. MacCulloch rated Tourmaline Oil "hold." The shares could then be had for $60.74, $65.26 and $60.87.